Companies / Hexagon Bio

Hexagon Bio

Menlo Park, United States

Hexagon Bio discovers and develops novel antibody-drug conjugate payload mechanisms for cancer therapy

Hexagon Bio, based in Menlo Park, United States, has 8 investors on file, among them 8VC, ATEL Ventures and Casdin Capital. Its latest round on record is Series C+, 23 Oct 2026. Its site was last checked 12 Nov 2026: site answers.

hexagonbio.com

Funding

1 round on record

Latest roundSeries C+23 Oct 2026

Since that round1 monthno later round on record

Investors in its rounds54 with a VCinfo profile

Oct 2026Series C+Led by The Column Group, with Nextech Invest, 8VC, Deviation Capital and 1 other

Round sizes and total raised are on Fundup AI, our sister product for funding data.

SEC Form D filings

4 filings

$67.3M sold of $80.0M offered11 Oct 2022 $61.0M sold19 Jul 2021 $12.0M sold31 Jul 2018 $8.3M sold of $8.4M offered20 Jul 2017

Filed by Hexagon Bio Inc. with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

8 investors on file

Investor	Evidence	Type
8VC	Portfolio page	Venture capital
ATEL Ventures	Portfolio page	Investor
Casdin Capital	Portfolio page	Venture capital
Deviation Capital	Portfolio page	Venture capital
Nextech Invest	Page + round	Venture capital
SoftBank Vision Fund	Portfolio page	Venture capital
The Column Group	Page + round	Venture capital
Trancos Ventures	Portfolio page	Venture capital

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

At a glance

Latest round: Series C+, 23 Oct 2026
Investors on file: 8
Employees: 51-200
Headquarters: Menlo Park, United States
Open roles: 1
Site: Answers
Last checked: 12 Nov 2026

Company data by Fundup AI.

Backed by the same investors

Companies sharing two or more investors with Hexagon Bio.

Oric Pharmaceuticals3 shared

Relay Therapeutics3 shared

Revolution Medicines3 shared

Vividion Therapeutics3 shared

10x Genomics2 shared

A2 Biotherapeutics2 shared

Get this company as JSON

GET /v1/companies/hexagonbio.com
GET /v1/companies/hexagonbio.com/investors
GET /v1/companies/hexagonbio.com/news

API docs · Get a free key · Your API key

Raising a round?

See which investors fit your startup, ranked by what they actually back.

Check investor fit

Free account · no card

Get Hexagon Bio and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when 8VC adds a company.

Work email, sign-in link by email. Already have an account? Log in

Your API key Read the docs

Ask AI5 plain-English investor searches a day
Full listsEvery portfolio row and two-firm overlap
API and MCP100 REST or MCP calls a month, one key
AlertsFollow 5 investors for portfolio and fund changes

VCinfo API

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/hexagonbio.com/investors

# also
GET /v1/companies/hexagonbio.com
GET /v1/companies/hexagonbio.com/news

The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing